Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
Hs 578T | GSK2334470 | 0.031622777 | 0.8622 | 0.02346 |
Hs 578T | GSK2334470 | 0.1 | 0.8718 | -0.01284 |
Hs 578T | GSK2334470 | 0.1 | 0.8778 | 0.04998 |
Hs 578T | GSK2334470 | 0.1 | 0.9162 | -0.02435 |
Hs 578T | GSK2334470 | 0.316227766 | 0.8199 | -0.02018 |
Hs 578T | GSK2334470 | 0.316227766 | 0.7938 | -0.02597 |
Hs 578T | GSK2334470 | 0.316227766 | 0.8455 | -0.05993 |
Hs 578T | GSK2334470 | 1.0 | 0.7810 | -0.03527 |
Hs 578T | GSK2334470 | 1.0 | 0.7501 | 0.03510 |
Hs 578T | GSK2334470 | 1.0 | 0.7781 | -0.03690 |
Hs 578T | GSK2334470 | 3.16227766 | 0.7619 | -0.00741 |
Hs 578T | GSK2334470 | 3.16227766 | 0.7366 | -0.01322 |
Hs 578T | GSK2334470 | 3.16227766 | 0.7111 | -0.00243 |
Hs 578T | GSK2334470 | 10.0 | 0.5336 | -0.05933 |
Hs 578T | GSK2334470 | 10.0 | 0.5468 | -0.00883 |
Hs 578T | GSK2334470 | 10.0 | 0.5381 | -0.02636 |
Hs 578T | Ribociclib | 0.001 | 0.8039 | 0.08289 |
Hs 578T | Ribociclib | 0.001 | 0.8726 | 0.13361 |
Hs 578T | Ribociclib | 0.001 | 0.8019 | 0.01891 |
Hs 578T | Ribociclib | 0.003162278 | 0.8539 | 0.07112 |
Hs 578T | Ribociclib | 0.003162278 | 0.7854 | 0.09130 |
Hs 578T | Ribociclib | 0.003162278 | 0.8616 | 0.07266 |
Hs 578T | Ribociclib | 0.01 | 0.7360 | 0.08089 |
Hs 578T | Ribociclib | 0.01 | 0.7315 | 0.13744 |
Hs 578T | Ribociclib | 0.01 | 0.7260 | 0.10798 |